In 2020, Asia accounted for more than a quarter of worldwide Prostate cancer incidence cases, with China and Japan together contributing over 220,000 new cases in the region.
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…
Hong Kong - Novotech, the leading Asia P
Read more